Related Experiment Video
Updated: May 23, 2026

15:48
ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Alagille syndrome: an overview
Pietro Vajro1, Lorenza Ferrante, Giulia Paolella
1Medical School of Salerno, Salerno, Italy. pvajro@unisa.it
Clinics and Research in Hepatology and Gastroenterology
|April 24, 2012
Summary
Alagille syndrome, a genetic disorder caused by JAG1 gene mutations, affects multiple organs. Key features include liver disease with neonatal cholestasis and heart abnormalities, impacting patient prognosis.
Area of Science:
- Genetics
- Pediatrics
- Hepatology
Background:
- Alagille syndrome is a genetic disorder affecting multiple organ systems.
- It results from mutations in the JAG1 gene and exhibits autosomal dominant inheritance with variable expressivity.
- Neonatal cholestasis due to paucity of intrahepatic bile ducts is a hallmark feature.
Purpose of the Study:
- To summarize the key clinical features and genetic basis of Alagille syndrome.
- To highlight the spectrum of disease manifestations, including liver, cardiac, and skeletal abnormalities.
- To discuss the prognostic factors and potential complications of Alagille syndrome.
Main Methods:
- Review of existing literature on Alagille syndrome.
- Analysis of clinical case reports and genetic studies.
- Synthesis of information regarding embryofoetopathy, JAG1 gene mutations, and associated phenotypes.
Main Results:
- Alagille syndrome presents with a distinct set of features including peculiar facies, cardiac defects, butterfly vertebrae, and ocular embryotoxon.
- Liver disease, characterized by paucity of bile ducts, can lead to severe cholestasis, pruritus, xanthomas, and potentially cirrhosis.
- Hepatocarcinoma has been reported as a rare complication.
Conclusions:
- Alagille syndrome is a complex genetic disorder with significant variability in clinical presentation.
- Prognosis is largely determined by the severity of hepatic and cardiac involvement.
- Early diagnosis and comprehensive management are crucial for improving outcomes in affected individuals.
Related Concept Videos
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Gastritis-II: Pathophysiology
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis-I: Introduction and Types
Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

